CompaniesTexas Biotechnology

Texas Biotechnology

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

180

By Phase

PHASE2/PHASE3: 1

By Status

UNKNOWN: 1

Clinical Trials Pipeline

No trials with date information available

Recent Trials

NCT00034307Lead Sponsor

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

PHASE2/PHASE3Unknown

180 participants

Funding History (20)

8-K

Jun 16, 2008

DEFM14C

May 20, 2008

8-K

Apr 7, 2008

8-K

Mar 25, 2008

8-K

Mar 17, 2008

8-K

Mar 6, 2008

8-K

Feb 25, 2008

8-K

Feb 22, 2008

8-K

Feb 19, 2008

8-K

Feb 1, 2008